Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
Scientific Reports
|
May 8, 2019
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
Takayuki Hirono, Kentaro Jingushi, Toshiyuki Nagata, et al.
Cancer Science
|
October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma
Toshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
Scientific Reports
|
April 22, 2021
ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
Kentaro Jingushi, Masaya Aoki, Kazuhiro Ueda, et al.
Oncology
|
September 14, 2022
Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer
Takayuki Ando, Ayumu Hosokawa, Miho Sakumura, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 18, 2021
Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS
Takahiro Kogaki, Ikumi Ohshio, Hasumi Ura, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
Scientific Reports
|
May 8, 2019
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
Takayuki Hirono, Kentaro Jingushi, Toshiyuki Nagata, et al.
Cancer Science
|
October 7, 2017
Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma
Toshiro Kinouchi, Motohide Uemura, Cong Wang, et al.
Scientific Reports
|
April 22, 2021
ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
Kentaro Jingushi, Masaya Aoki, Kazuhiro Ueda, et al.
Oncology
|
September 14, 2022
Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer
Takayuki Ando, Ayumu Hosokawa, Miho Sakumura, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 18, 2021
Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS
Takahiro Kogaki, Ikumi Ohshio, Hasumi Ura, et al.
Page
of 8